Is this healthcare landlord built for scale?
Ventas Inc is a real estate company focused on healthcare-
Are rising revenues masking weak returns?
FundamentalsFor 2025 (reported in USD), revenue was USD 4.3 billion and net income was USD 261.5 million, alongside a 26.7% year-over-year revenue increase. Profitability in the trailing period shows a 13.91% operating margin and a 4.25% net profit margin, with ROE at 2.04%, keeping the returns picture muted relative to the business’s scale.
Cash and balance-sheet figures were sizable in absolute terms, with USD 741.1 million of cash against USD 13.0 billion of total debt. Depreciation and amortization ran at USD 1.4 billion, while capital spending was USD 363.9 million, a mix that affects how much accounting profit converts into investable returns.
Is the market overpaying for improvement?
DCF / MultiplesAt USD 84.42, the stock sits between a weaker-outcome value of USD 68.28 and a stronger-outcome value of USD 147.05, with a central estimate of USD 103.52. That placement contrasts with headline pricing like a 157.15 P/E and 24.31 EV/EBITDA, which indicate a market paying up for future improvement rather than one anchored to today’s trailing earnings power.
Returns Must Catch Up
TakeawayThe setup is oddly split between low returns and a demanding price. For this to work, returns on capital need to rise meaningfully. If margins and earnings stay thin, the valuation can compress fast. If returns improve, the current price may be understating that upside.